From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature.


Journal

Annals of diagnostic pathology
ISSN: 1532-8198
Titre abrégé: Ann Diagn Pathol
Pays: United States
ID NLM: 9800503

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 06 12 2022
accepted: 07 12 2022
pubmed: 23 12 2022
medline: 4 1 2023
entrez: 22 12 2022
Statut: ppublish

Résumé

T-prolymphocytic leukemia (T-PLL) is a rare, aggressive T-cell leukemia, and patients typically present with marked peripheral blood lymphocytosis. Approximately 15-20 % of patients may present with moderate and relative stable lymphocytosis and an indolent clinical course that can persist for a few years. However, eventually these patients go on to develop marked lymphocytosis and rapidly progressive disease. We report a 72-year-old man who presented with multicompartmental lymphadenopathy and a normal complete blood count. Excision of left and right cervical lymph nodes showed replacement of the lymph node architecture by a small T-cell neoplasm positive for CD3, CD4, CD5, CD7 and TCL-1, and negative for CD8, CD20, CD30 and ALK. Subsequent bone marrow evaluation showed minimal bone marrow involvement by a T-cell neoplasm associated with TCL1A rearrangement in 11 % of cells supporting the diagnosis of T-PLL. Despite treatment, he showed progressive lymphadenopathy while remarkably maintaining normal white blood cell counts until he eventually developed leukocytosis of 110.9 × 10

Identifiants

pubmed: 36549077
pii: S1092-9134(22)00179-4
doi: 10.1016/j.anndiagpath.2022.152077
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

152077

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Karen A Nahmod (KA)

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Beenu Thakral (B)

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

F N U Aakash (FNU)

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Swaminathan P Iyer (SP)

Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

L Jeffrey Medeiros (LJ)

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Andres E Quesada (AE)

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Electronic address: aquesada@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH